Overview of HIV infection

被引:11
作者
Temesgen, Z [1 ]
机构
[1] Mayo Clin, HIV Clin, Div Infect Dis, Rochester, MN 55905 USA
关键词
D O I
10.1016/S1081-1206(10)63503-X
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Learning objective: To understand the current status of infection with the human immunodeficiency virus (HIV), including epidemiology, treatment, and recent advances. Data sources: Relevant articles and publications from the medical literature, including the Joint United Nations Programme on HIV/AIDS (UNAIDS) 'Report on the global HIV/AIDS epidemic,' and information from recently held conferences. Conclusions: Now in its second decade, HIV infection has become a global pandemic, affecting communities throughout the world. Ninety percent of people with HIV live in developing countries. In these countries, HIV/AIDS has taken a heavy toll on economic, social, and family structures. It is responsible for a large proportion of adult deaths causing millions of children to be orphaned. The situation is different in the industrialized world, including the United States. Here, reports indicate that death and incidence rates as well as the development of opportunistic infections have been drastically reduced. These reductions are in part due to improved prevention efforts but mainly due to recent advances in the management of HIV infection, including the availability of new therapies.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 32 条
[1]  
[Anonymous], 1998, MMWR Recomm Rep, V47, P1
[2]  
[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1
[3]  
[Anonymous], 1996, Lancet, V348, P283
[4]  
Bell David M., 1997, American Journal of Medicine, V102, P9, DOI 10.1016/S0002-9343(97)89441-7
[5]   A case-control study of HIV seroconversion in health care workers after percutaneous exposure [J].
Cardo, DM ;
Culver, DH ;
Ciesielski, CA ;
Srivastava, PU ;
Marcus, R ;
Abiteboul, D ;
Heptonstall, J ;
Ippolito, G ;
Lot, F ;
McKibben, P ;
Bell, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21) :1485-1490
[6]   Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86
[7]  
*CDCP, 1996, MMWR-MORBID MORTAL W, V45, P468
[8]  
*CDCP, 1997, HIV AIDS SURV REP, V9, P2
[9]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[10]   Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection [J].
Coombs, RW ;
Welles, SL ;
Hooper, C ;
Reichelderfer, PS ;
DAquila, RT ;
Japour, AJ ;
Johnson, VA ;
Kuritzkes, DR ;
Richman, DD ;
Kwok, S ;
Todd, J ;
Jackson, JB ;
DeGruttola, V ;
Crumpacker, CS ;
Kahn, J .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :704-712